STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
294
13F, latest reported quarter
Conversions, 180 days
11
Codes C/M, not in net · $16.6M priced
What the filings say about THG
Insiders, 180 days
-$11.4M net sold
9 sellers · 23% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-12
Planned sales (Form 144), 90 days
$4.7M
5 notices
Hanover Insurance insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HANOVER INSURANCE GROUP, INC. insiders sold a net $11.4M of stock across 106 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Aug 19, 2026.
The trade is 2.9% of the 13,706 shares held after it.
2 other insiders sold within 30 days.
294 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Kerrigan Dennis Francis sold about $88.0K of THG under a 10b5-1 plan on Aug 20, 2026; 2 other insiders sold within 30 days and 294 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Aug 19, 2026.
The trade is 14.2% of the 12,002 shares held after it.
2 other insiders sold within 30 days.
294 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Kerrigan Dennis Francis sold about $379.9K of THG under a 10b5-1 plan on Aug 20, 2026; 2 other insiders sold within 30 days and 294 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 20, 2026.
The trade is 35.1% of the 13,731 shares held after it.
2 other insiders sold within 30 days.
294 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Kerrigan Dennis Francis sold about $1.1M of THG under a 10b5-1 plan on Aug 19, 2026; 2 other insiders sold within 30 days and 294 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 20, 2026.
The trade is 12.3% of the 12,226 shares held after it.
2 other insiders sold within 30 days.
294 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Kerrigan Dennis Francis sold about $333.7K of THG under a 10b5-1 plan on Aug 19, 2026; 2 other insiders sold within 30 days and 294 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 20, 2026.
The trade is 1.9% of the 12,002 shares held after it.
2 other insiders sold within 30 days.
294 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Kerrigan Dennis Francis sold about $49.9K of THG under a 10b5-1 plan on Aug 19, 2026; 2 other insiders sold within 30 days and 294 funds added in the latest 13F quarter.
106 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
THG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Lowsley Denise
Filed 2026-09-16
$2.3M
Kerrigan Dennis Francis
Filed 2026-08-20
$467.9K
Kerrigan Dennis Francis
Filed 2026-08-19
$1.4M
Bunting Theodore H JR
Filed 2026-08-10
$274.9K
JANE D CARLIN
Filed 2026-08-03
$231.5K
THG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Touchstone Funds Group Trust-Touchstone Small Cap Fund
$8.2M position · as of 2026-06-30
3.3%
Opus Small Cap Value ETF
$22.1M position · as of 2026-07-31
3.1%
Allspring Special Global Small Cap Fund
$3.2M position · as of 2026-07-31
2.8%
Hunter Small Cap Value Fund
$1.8M position · as of 2026-07-31
2.7%
CresAlta Small and Mid-Cap ETF
$2.5M position · as of 2026-07-31
2.6%
Carillon Chartwell Mid Cap Value Fund
$474.1K position · as of 2026-06-30
2.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$10.5M
$15.4M
$3.4M
+76%
+134%
2024
$9.6M
$13.1M
$3.1M
+46%
+113%
2023
$7.7M
$5.8M
$2.5M
+12%
+57%
2022
$6.8M
$7.3M
$2.2M
+21%
+42%
2021
$6.8M
$8.4M
$2.2M
+15%
+19%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $11.4M sold by insiders over 180 days, 294 funds added last quarter, $4.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM THG
FY Dec 2025
$6.6B
FY Dec 2024
$6.2B
FY Dec 2023
$6.0B
FY Dec 2022
$5.5B
FY Dec 2021
$5.2B
Jun 2026
$1.7B
Mar 2026
$1.7B
Dec 2025
$1.7B
Sep 2025
$1.7B
Jun 2025
$1.7B
Mar 2025
$1.6B
Dec 2024
$1.6B
Sep 2024
$1.6B
At each fiscal year end
Single quarter
Net margin, TTM
+11.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM THG
FY Dec 2025
+10.0%
FY Dec 2024
+6.8%
FY Dec 2023
+0.6%
FY Dec 2022
+2.1%
FY Dec 2021
+8.1%
Jun 2026
+11.1%
Mar 2026
+11.0%
Dec 2025
+11.9%
Sep 2025
+10.7%
Jun 2025
+9.5%
Mar 2025
+8.0%
Dec 2024
+10.6%
Sep 2024
+6.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.3B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM THG
FY Dec 2025
$1.2B
FY Dec 2024
$796.2M
FY Dec 2023
$349.8M
FY Dec 2022
$704.5M
FY Dec 2021
$815.7M
Jun 2026
$209.4M
Mar 2026
$115.3M
Dec 2025
$377.0M
Sep 2025
$551.4M
Jun 2025
$204.9M
Mar 2025
$37.1M
Dec 2024
$210.5M
Sep 2024
$392.3M
At each fiscal year end
Single quarter
Debt to equity
0.23x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity THG
FY Dec 2025
0.34x
FY Dec 2024
0.28x
FY Dec 2023
0.34x
FY Dec 2022
0.30x
FY Dec 2021
0.23x
Jun 2026
0.23x
Mar 2026
0.24x
Dec 2025
0.34x
Sep 2025
0.37x
Jun 2025
0.24x
Mar 2025
0.26x
Dec 2024
0.28x
Sep 2024
0.29x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.50x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt THG
FY Dec 2025
0.97x
FY Dec 2024
1.03x
FY Dec 2023
0.43x
FY Dec 2022
1.02x
FY Dec 2021
1.16x
Jun 2026
1.50x
Mar 2026
1.49x
Dec 2025
0.97x
Sep 2025
0.79x
Jun 2025
1.09x
Mar 2025
1.00x
Dec 2024
1.03x
Sep 2024
0.82x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+21.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity THG
FY Dec 2025
+20.7%
FY Dec 2024
+16.1%
FY Dec 2023
+1.5%
FY Dec 2022
+4.2%
FY Dec 2021
+13.3%
Jun 2026
+21.9%
Mar 2026
+21.8%
Dec 2025
+20.7%
Sep 2025
+20.0%
Jun 2025
+19.3%
Mar 2025
+15.8%
Dec 2024
+16.1%
Sep 2024
+14.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets THG
FY Dec 2025
+4.1%
FY Dec 2024
+2.9%
FY Dec 2023
+0.2%
FY Dec 2022
+0.8%
FY Dec 2021
+3.1%
Jun 2026
+4.6%
Mar 2026
+4.5%
Dec 2025
+4.1%
Sep 2025
+3.9%
Jun 2025
+3.6%
Mar 2025
+2.9%
Dec 2024
+2.9%
Sep 2024
+2.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+20.1%
operating income after a 22.0% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital THG
FY Dec 2025
+20.0%
FY Dec 2024
+16.8%
FY Dec 2023
+2.9%
FY Dec 2022
+7.3%
FY Dec 2021
+9.4%
Jun 2026
+20.1%
Mar 2026
+20.1%
Dec 2025
+20.0%
Sep 2025
+18.9%
Jun 2025
+18.8%
Mar 2025
+16.6%
Dec 2024
+16.8%
Sep 2024
+14.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed THG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.26x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing THG
FY Dec 2025
10.06x
FY Dec 2024
13.22x
FY Dec 2023
125.18x
FY Dec 2022
42.10x
FY Dec 2021
11.31x
Jun 2026
10.23x
Mar 2026
8.73x
Dec 2025
10.06x
Sep 2025
10.50x
Jun 2025
11.18x
Mar 2025
14.47x
Dec 2024
13.22x
Sep 2024
14.65x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$8.8B
market value at close 2026-10-27 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value THG
FY Dec 2025
$6.6B
FY Dec 2024
$5.9B
FY Dec 2023
$4.9B
FY Dec 2022
$5.2B
FY Dec 2021
$5.1B
Jun 2026
$8.1B
Mar 2026
$6.7B
Dec 2025
$6.6B
Sep 2025
$6.9B
Jun 2025
$6.6B
Mar 2025
$6.7B
Dec 2024
$5.9B
Sep 2024
$5.7B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+15.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield THG
FY Dec 2025
+18.0%
FY Dec 2024
+14.3%
FY Dec 2023
+8.1%
FY Dec 2022
+14.7%
FY Dec 2021
+17.5%
Jun 2026
+16.7%
Mar 2026
+20.5%
Dec 2025
+18.0%
Sep 2025
+15.5%
Jun 2025
+13.8%
Mar 2025
+12.4%
Dec 2024
+14.3%
Sep 2024
+12.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.30x
P/E over trailing EPS growth of 38%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing THG
FY Dec 2025
0.18x
FY Dec 2024
0.01x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.52x
Jun 2026
0.27x
Mar 2026
0.13x
Dec 2025
0.18x
Sep 2025
0.15x
Jun 2025
0.11x
Mar 2025
0.09x
Dec 2024
0.01x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
THG ranks highest on institutional and government (73rd percentile) and profitability (72nd), and lowest on insider conviction (13th), among Insurance peers.
Profitability
72
Inputs
Return on equity+21.9% · 74 pct, sector of 116
Return on assets+4.6% · 68 pct, sector of 122
Return on invested capital+20.1% · 74 pct, universe of 1,069
Return on capital employedassets or current liabilities not filed
Financial health
68
Inputs
Debt to equity0.23x · 60 pct, sector of 104
Cash flow to debt1.50x · 75 pct, sector of 97
Growth
38
Inputs
Revenue growth, YoY+5.7% · 38 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
13
Inputs
Net Form 4 buying (codes P and S), 180d-$9.4M · 25 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
73
Inputs
Funds adding, latest quarter294 · 73 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
47
Inputs
Short interest, % of float+3.0% · 57 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.0% · 37 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
THG filings, in plain words
Are Hanover Insurance insiders buying or selling THG?
In the 180 days to 2026-10-28, Hanover Insurance insiders were net sellers, a net $11.4M across purchases and sales reported on Form 4, by 9 sellers.
Have members of Congress traded THG?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Jefferson Shreve dated 2025-05-12.
Are there planned insider sales of THG?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $4.7M of stock; the latest, by Lowsley Denise, was filed 2026-09-16.
Read the full summary
In the 180 days to 2026-10-28, Hanover Insurance insiders were net sellers of THG, a net $11.4M across purchases and sales reported on Form 4 by 9 sellers. 23% of the 22 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in THG, none in the last year; the latest on record is a sale by Jefferson Shreve dated 2025-05-12. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $4.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.